The broader context: why compounded semaglutide uses units Understanding why this confusion exists in the first place helps frame the entire issue
Because the available evidence is largely preclinical, any benefits for androgenetic alopecia or other forms of hair loss in humans remain unproven
Drugs like Ozempic, Wegovy, Mounjaro, Zepbound, or their compounded identical generics (like semaglutide injections) are popular because of their effectiveness and in spite of their usually high cost
A spokesperson for Eli Lilly, which produces Zepbound and Mounjaro, told The Independent that Zepbound and Mounjaro autoinjectors and Zepbound vials are approved for single-use onlydose-splitting or microdosing is not contemplated by the FDA-label and may pose patient safety risks. Novo Nordisk, which produces Ozempic and Wegovy, told The Independent the company "[does] not condone the misuse of our products." The company noted it is concerned about non-FDA approved knock-off versions of semaglutide and sources spreading misinformation about GLP-1s to the public. The FDA warns that using unapproved versions of GLP-1 drugs can be risky for patients. This story was updated on September 4, 2025 to include responses from Eli Lilly and Novo Nordisk Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments
Recently, a family member told me they were planning to start a GLP-1 medication
et al., 2024)
